HBV Cure is developed by the Singapore Hepatitis B Consortium who have been working collaboratively to focus on the eradication of Chronic Hepatitis B, through a comprehensive approach via 3 integrated themes: DEFINE host/viral interactions, TARGET discovery with validation, and EXPERIMENTAL therapeutics.

Meet our Researchers
They are leaders in the field of HBV research who have made significant contributions to our understanding of the pathogenesis and treatment of chronic HBV disease both at a basic and clinical level. Their leadership and international standing is documented by publications in the highest impact Journals.